Allergan, Inc.
NYSE: AGN
$193.02
+$0.03 (+0.0%)
Closing Price on May 8, 2020
AGN Articles
A new addition to the Merrill Lynch US 1 list, plus four additional stocks that offer a fair degree of safety and solid dependable dividends. With the market volatility spiking, it makes sense to...
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Thursday included Allergan, Boeing, Facebook, GoPro, Microsoft, Pfizer, Royal Dutch Shell, ServiceNow and Tiffany.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Wednesday included Allergan, Apple, Carnival, Ciena, Juniper Networks, Lockheed Martin, Plug Power, Take-Two Interactive Software, United...
Published:
Last Updated:
Tuesday was a down day for the broad U.S. markets. We are now in the busiest week of this earnings season with 12 Dow components reporting. If anything these major companies will set a direction for...
Published:
Last Updated:
Here are five top health care stocks that provide investors with different avenues to invest in the sector. They all should be solid additions to growth portfolios for 2019.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Thursday include Aetna, Analog Devices, Lowe's, Merck, Pfizer, Plug Power, Qualcomm and Target.
Published:
Big Pharma is looking good for investors in the second half of 2018. That's the message from the research team at Bank of America Merrill Lynch.
Published:
Last Updated:
Golden crosses, typically seen as a bullish sign, recently happened to shares of Tesla and others, while death crosses, a bearish sign, occurred at Schlumberger and others.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Thursday include Allergan, Cheniere Energy, Clean Energy, Facebook, Fiat Chrysler, Intel and NetApp.
Published:
Last Updated:
Merrill Lynch released its high-conviction ideas for the third quarter ahead of the Independence Day holiday. These picks are based on the firm's views of potential significant market and...
Published:
Last Updated:
There is deep value for long-term investors in these specialty pharmaceutical companies, and the ability to buy in to some of the best companies in the industry at rock bottom pricing.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Tuesday include Alcoa, Alphabet, BP, Epizyme, FirstEnergy, First Solar, KeyCorp, Nvidia and Vale.
Published:
Last Updated:
Here are the latest addition to the Merrill Lynch US 1 list and three current list members that have big upside to their price targets.
Published:
Last Updated:
Dermira, BRF, Park Hotels & Resorts, and Allergan all posted new 52-week lows Monday.
Published:
Last Updated:
While chasing what portfolio managers own isn’t always the best idea, many people have made a lot of money by simply mimicking what legendary investors like Warren Buffett hold.
Published:
Last Updated: